OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers.
Published in:
British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1240, doi. 10.1111/j.1365-2125.2012.04471.x
By:
- Stoch, S. Aubrey;
- Zajic, Stefan;
- Stone, Julie A.;
- Miller, Deborah L.;
- Bortel, Lucas;
- Lasseter, Kenneth C.;
- Pramanik, Barnali;
- Cilissen, Caroline;
- Liu, Qi;
- Liu, Lida;
- Scott, Boyd B.;
- Panebianco, Deborah;
- Ding, Yu;
- Gottesdiener, Keith;
- Wagner, John A.
Publication type:
Article
Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.
Published in:
Diabetes, 2018, v. 67, n. 6, p. 1105, doi. 10.2337/db17-1331
By:
- Shankar, Sudha S.;
- Shankar, R. Ravi;
- Mixson, Lori A.;
- Miller, Deborah L.;
- Pramanik, Barnali;
- O’Dowd, Amy K.;
- Williams, Donna M.;
- Frederick, Clay B.;
- Beals, Chan R.;
- Stoch, S. Aubrey;
- Steinberg, Helmut O.;
- Kelley, David E.
Publication type:
Article